Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Dec 7;95(6):1383-1385.
doi: 10.4269/ajtmh.16-0230. Epub 2016 Sep 26.

Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis

Golam Hasnain  1   2 , Mohammad Sohel Shomik  2 , Prakash Ghosh  2 , Mamun Or Rashid  2 , Shakhawat Hossain  2 , Shinjiro Hamano  3 , Dinesh Mondal  4
Affiliations
Case Reports

Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis

Golam Hasnain et al. Am J Trop Med Hyg. .

Abstract

Post-kala-azar dermal leishmaniasis (PKDL) without previous visceral leishmaniasis (VL) is a rare dermatological manifestation of Leishmania infection. To date, most of the reported cases neither showed parasitological confirmation nor explained the outcome of treatment. Herein, we report three confirmed cases that were were successfully cured after miltefosine treatment.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Rash before treatment.
Figure 2.
Figure 2.
Rash after treatment.
See this image and copyright information in PMC

References

    1. World Health Organization (WHO) Post-Kala-Azar Dermal Leishmaniasis: A Manual for Case Management and Control: Report of a Consultative Meeting, Kolkata, India, July 2–3, 2012. Geneva, Switzerland: WHO; 2013. http://apps.who.int/iris/bitstream/10665/78608/1/9789241505215_eng.pdf Available at. Accessed October 14, 2014.
    1. Zijlstra EE, Musa AM, Khalil EAG, El Hassan IM. Post kala-azar dermal leishmaniasis. Lancet Infect Dis. 2003;3:87–98. - PubMed
    1. World Health Organization (WHO) Kala-Azar Elimination Program: Report of a WHO Consultation of Partners, Geneva, Switzerland, 10–11 February 2015. Geneva, Switzerland: WHO; 2015. http://apps.who.int/iris/bitstream/10665/185042/1/9789241509497_eng.pdf Available at. Accessed February 4, 2016.
    1. el-Hassan AM, Ghalib HW, Zylstra E, Eltoum IA, Ali MS, Ahmed HM. Post kala-azar dermal leishmaniasis in the absence of active visceral leishmaniasis. Lancet. 1990;336:750. - PubMed
    1. Pal D, Naskar A, Ghosh MK. A case of miltefosine responsive pleomorphic post kala-azar dermal leishmaniasis. Braz J Infect Dis. 2013;17:610–612. - PMC - PubMed

Publication types

LinkOut - more resources